- Home
- About Us
- Our Products
- Investors
- News
- New Product Pipeline
- Contact Us
Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced it had raised A$7.2 million from its
Share Purchase Plan which closed on 24 June 2009. Shareholders of the company were
given the opportunity to purchase up to $5,000 worth of shares each at the $2.35 price
paid by institutional investors in the recent placement.
Full Release - Pharmaxis Closes Share Purchase Plan